Tower Research Capital LLC (Trc) Enzo Biochem Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Enzo Biochem Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,414 shares of ENZ stock, worth $1,786. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,414
Previous 4,263
43.37%
Holding current value
$1,786
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding ENZ
# of Institutions
48Shares Held
15.5MCall Options Held
2.3KPut Options Held
0-
Harbert Fund Advisors, Inc. Birmingham, AL5.18MShares$3.83 Million3.43% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.53MShares$1.87 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$1.39 Million0.0% of portfolio
-
Potomac Capital Management, Inc.1.48MShares$1.1 Million3.63% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$987,5149.62% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $36.1M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...